Your browser doesn't support javascript.
loading
Endomembrane targeting of human OAS1 p46 augments antiviral activity.
Soveg, Frank W; Schwerk, Johannes; Gokhale, Nandan S; Cerosaletti, Karen; Smith, Julian R; Pairo-Castineira, Erola; Kell, Alison M; Forero, Adriana; Zaver, Shivam A; Esser-Nobis, Katharina; Roby, Justin A; Hsiang, Tien-Ying; Ozarkar, Snehal; Clingan, Jonathan M; McAnarney, Eileen T; Stone, Amy El; Malhotra, Uma; Speake, Cate; Perez, Joseph; Balu, Chiraag; Allenspach, Eric J; Hyde, Jennifer L; Menachery, Vineet D; Sarkar, Saumendra N; Woodward, Joshua J; Stetson, Daniel B; Baillie, John Kenneth; Buckner, Jane H; Gale, Michael; Savan, Ram.
Afiliação
  • Soveg FW; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.
  • Schwerk J; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.
  • Gokhale NS; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.
  • Cerosaletti K; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.
  • Smith JR; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.
  • Pairo-Castineira E; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.
  • Kell AM; Benaroya Research Institute at Virginia Mason, Seattle, United States.
  • Forero A; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.
  • Zaver SA; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.
  • Esser-Nobis K; Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
  • Roby JA; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.
  • Hsiang TY; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.
  • Ozarkar S; Department of Molecular Genetics and Microbiology, School of Medicine, University of New Mexico, Albuquerque, United States.
  • Clingan JM; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.
  • McAnarney ET; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.
  • Stone AE; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, United States.
  • Malhotra U; Department of Microbiology, School of Medicine, University of Washington, Seattle, United States.
  • Speake C; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.
  • Perez J; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.
  • Balu C; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.
  • Allenspach EJ; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.
  • Hyde JL; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.
  • Menachery VD; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.
  • Sarkar SN; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.
  • Woodward JJ; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.
  • Stetson DB; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.
  • Baillie JK; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.
  • Buckner JH; Department of Microbiology and Immunology, University of Texas Medical Center, Galveston, United States.
  • Gale M; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.
  • Savan R; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.
Elife ; 102021 08 03.
Article em En | MEDLINE | ID: mdl-34342578

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: 2',5'-Oligoadenilato Sintetase / SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: Elife Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: 2',5'-Oligoadenilato Sintetase / SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: Elife Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos